Click here to see a list of our past events.
Center for Technology Licensing (CTL) at Weill Cornell Medicine Office Hours are open to all who wish to gain more information about the advancement of their patent filings and to discuss their technology venture project with a one-on-one meeting with a Weill Cornell Business Development and Licensing Professional. The June 5th office hours will be hosted by Donna Rounds, Ph.D., Associate Director, Business Development and Licensing.
Donna joined the startup world as one of the founders of Physiome Sciences, Inc., the first in-silico drug discovery platform using computational models of cells, tissues and organs. She later joined the British Technology Group (BTG Plc) as a technology scout, where she visited academic institutions across the East Coast searching for biotech projects in the early stages of development. Later, Donna joined Columbia Technology Ventures (CTV) and managed a portfolio of world-class scientists and Nobel laureates at Columbia University Vagelos College of Physicians and Surgeons. She was later recruited to lead the technology development program at Hospital for Special Surgery with a focus on musculoskeletal innovations and medical devices in orthopedics and rheumatology. Donna was on the scientific advisory board of Tohi Ventures and co-founded Nirova BioSense, which is dedicated to the development of optical sensors for real-time detection of ovarian cancer biomarkers.
Register here for your 30-minute private session. Click the right arrow on top of the calendar to choose the month of June and click 5 on the June calendar to choose the time you prefer.
Join us for an insightful panel discussion on the critical challenges and opportunities in bringing pharmaceutical innovations to market. This dynamic session will explore key aspects of the drug commercialization journey, including regulatory strategy and market access considerations. Panelists will share their experiences in successfully launching new therapeutics while addressing evolving health care landscapes and stakeholder demands.
Panelists:
- Alexander Brown, COO of Convergent Therapeutics
- Dr. Neil Bander, CSO, Co-Founder of Convergent Therapeutics
- Dr. Philip Kantoff, CEO, Co-Founder of Convergent Therapeutics
- Dr. Scott Tagawa, Professor of Medicine at Weill Cornell Medicine
Hosted by Brian Kelly, director of technology licensing at Weill Cornell Medicine
Center for Technology Licensing (CTL) at Weill Cornell Medicine Office Hours are open to all who wish to gain more information about the advancement of their patent filings and to discuss their technology venture project with a one-on-one meeting with a Weill Cornell Business Development and Licensing Professional. The May 22nd office hours will be hosted by Jamie Brisbois, Ph.D., Manager, Business Development and Licensing.
Jamie collaborates with Weill Cornell Medicine innovators to identify, market and license life sciences technologies. Prior to joining the Center for Technology Licensing in 2021, Jamie worked as a consultant with ClearView Healthcare Partners, a boutique health care consulting firm based in Boston. In addition, he served three years as a fellow with Columbia Technology Ventures (CTV), the technology transfer office of Columbia University.
Register here for your 30-minute private session.
Join us for a virtual presentation exploring the practical implications of incorporating artificial intelligence (AI) tools in academic research and innovation. As AI becomes increasingly integrated into research methodologies, understanding how to properly document and manage AI assistance in the invention process is crucial for protecting intellectual property rights.
This interactive session will address key concerns facing researchers, including:
- Strategic approaches to incorporating AI tools in your research workflow
- Best practices for documenting AI assistance during invention conception and development
- Practical guidelines for maintaining transparent records of AI interactions (prompts and outputs)
- Protecting IP potential while leveraging AI capabilities
- Understanding the concept of hybrid inventorship in the AI era
Hosted by Martin Teschl, Director of BD & Licensing, our guest speaker David Sanker, Founder of Sanker IP, will provide actionable insights and practical frameworks for researchers looking to optimize their use of AI while safeguarding their intellectual property interests.
An infusion of non-dilutive funding like SBIR/STTR grants can propel a startup forward — but what comes after you win? Entrepreneurs are invited to join Rev: Ithaca Startup Works and Renata Dabrowska, CPA at Sciarabba Walker & Co., LLP, for a virtual content session focused on the crucial accounting steps after receiving an SBIR or STTR award.
In this informative session, Dabrowska will demystify post-award requirements and share best practices for compliant and strategic financial management. From setting up proper accounting systems to managing federal reporting and audits, attendees will walk away with actionable insights to help their ventures stay on track.
Admission is free and open to all. RSVP today.
Biotech XYZ, BioVenture eLab (a part of Enterprise Innovation), Chai Ventures, IndieBio, and SOSV are teaming up to host a collaborative event focused on the future of women’s health.
The Latest Innovations in Women’s Health will bring together leaders across biotech, venture, and research to explore cutting-edge advancements in the space. Instead of a traditional panel, we’re hosting an interactive format with breakout-style discussion pods led by experts and operators.
These are the six topics we’ll be diving into:
- Personalized Medicine for Hormone Health
- Bridging Gaps in Healthtech Funding
- Digital Therapeutics, Innovation & Clinical Trials in Women’s Health
- Lab to Market: Scaling Startups
- Aging, Longevity & Holistic Health
- Chronic Conditions That Disproportionately Impact Women
This is an invite-only gathering for founders, funders, researchers and operators passionate about advancing women’s health outcomes.
We hope you’ll join us for a thoughtful and energizing evening. RSVP by May 2nd to secure your spot! Your registration is subject to approval by the host.
Are you a STEM researcher interested in making an impact with your technology innovation? The National Science Foundation’s I-Corps program can provide you with professional training, mentoring, and up to $50,000 in funding for customer discovery.
Hosted by the Interior Northeast I-Corps Hub (IN I-Corps), the virtual NSF I-Corps Information Session is designed for busy graduate students, postdocs and faculty interested in learning more about I-Corps regional and national programming. NSF I-Corps instructor Ken Rother will be joined by Hunter Adams, a new instructor and program alum, to share their experience and answer questions.
The NSF created I-Corps (Innovation Corps) to bridge the gap between fundamental research discoveries in science and engineering and the commercialization of technologies, products and processes with the potential to benefit society.
Register here.
Ready to secure non-dilutive funding to take your startup to the next level?
Join Kirk Macolini, President of InteliSpark, LLC, for this virtual workshop providing insights into the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) application process. During the workshop, Macolini will discuss and answer questions regarding writing and submitting a successful SBIR/STTR proposal and identifying strategies for making your SBIR/STTR proposal more competitive.
Upon registering, participants will receive access to the SBIR/STTR video series, a set of short videos containing valuable background information, which they are encouraged to view prior to the workshop. The pre-workshop video series covers:
- An overview of the SBIR/STTR programs
- Program eligibility requirements
- Differences between SBIR and STTR agencies
- Using SBIR/STTR to enhance your company's value
The event is free and open to the public. Register to reserve your spot.
Center for Technology Licensing (CTL) at Weill Cornell Medicine Office Hours are open to all who wish to get an answer to their intellectual property questions and gain more information about the advancement of their IP filings with a one-on-one meeting.
The Tuesday, April 15, office hours will be hosted virtually by Eric Bryant, M.S., J.D., Intellectual Property Officer, Biomedical Sciences.
Eric holds a Master of Science in Biomedical Engineering from New York University, a Juris Doctor from New York Law School, and is a registered patent attorney. He works with the Weill Cornell office to execute on intellectual property strategy, review submitted invention disclosures, and manage domestic and foreign patent filings and patent prosecution. Eric’s expertise encompasses a variety of technologies including, but not limited to, diagnostics tools and methods, pharmaceuticals, controlled release therapeutic devices, respiratory devices, surgical tools, biological technologies and nanotechnology.
To reserve your private, 30-minute Zoom session with Eric, click here and select your preferred time.
Join our distinguished special panel to explore the critical intersection of medical device innovation and regulatory guidance. The panel will unpack the complex path from scientific discovery to market-ready medical innovation. We'll explore the strategic, technical and regulatory considerations that transform promising research into technologies that can improve patient care.
This session is ideal for anyone interested in medical devices and understanding the journey from idea to real-world healthcare applications.
Our expert panelists will share their practical insights on:
- Navigating FDA approval processes
- Balancing innovation with regulatory compliance
- Strategies for successful device development
- Emerging challenges in medical device development
Whether you're considering a new idea, commercialization, or actively developing medical device solutions, this panel offers valuable perspectives on turning promising research into market-ready medical devices.
Panelists:
- Mark Melkerson, former FDA Deputy Director, Office of Health Technology / CDRH / ODE and current MNM Consulting
- Thomas Roueche, President and CEO, Fesarius Therapeutics
- Jason Spector, M.D., Chief of the Division of Plastic and Reconstructive Surgery at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, Co-Founder of Fesarius Therapeutics
